Proof of Concept Study in Male and Female Intensive Care Patients to Investigate the Clinical Effect of Repetitive Orally Inhaled Doses of AP301 on Alveolar Liquid Clearance in Acute Lung Injury

Trial Profile

Proof of Concept Study in Male and Female Intensive Care Patients to Investigate the Clinical Effect of Repetitive Orally Inhaled Doses of AP301 on Alveolar Liquid Clearance in Acute Lung Injury

Completed
Phase of Trial: Phase II

Latest Information Update: 03 Mar 2015

At a glance

  • Drugs Solnatide (Primary)
  • Indications Acute lung injury; Pulmonary oedema
  • Focus Proof of concept; Therapeutic Use
  • Sponsors APEPTICO Forschung und Entwicklung
  • Most Recent Events

    • 28 Aug 2014 According to the European Clinical Trials Database record, status changed from active, no longer recruiting to completed.
    • 23 Aug 2014 New source identified and integrated (European Clinical Trials Database record: EudraCT2012-001863-64)
    • 09 Apr 2014 Topline results were reported in an Apeptico media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top